These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 18597824)
21. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT. Pe ML; Trabulsi EJ; Kedika R; Pequignot E; Dicker AP; Gomella LG; Valicenti RK Urology; 2009 Jun; 73(6):1328-34. PubMed ID: 19376564 [TBL] [Abstract][Full Text] [Related]
22. Sequential treatment for recurrent localized prostate cancer. Van Der Poel HG; Moonen L; Horenblas S J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820 [TBL] [Abstract][Full Text] [Related]
23. Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer. Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Lief JH; Adamovich E Am J Clin Oncol; 2008 Dec; 31(6):539-44. PubMed ID: 19060584 [TBL] [Abstract][Full Text] [Related]
24. Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm. Clarke HS; Eskridge MR; El-Zawahry AM; Keane TE Can J Urol; 2007 Dec; 14 Suppl 1():24-7. PubMed ID: 18163941 [TBL] [Abstract][Full Text] [Related]
26. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984 [TBL] [Abstract][Full Text] [Related]
27. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Onik G Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431 [TBL] [Abstract][Full Text] [Related]
28. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572 [TBL] [Abstract][Full Text] [Related]
29. Primary cryoablation nadir prostate specific antigen and biochemical failure. Levy DA; Pisters LL; Jones JS J Urol; 2009 Sep; 182(3):931-7. PubMed ID: 19616226 [TBL] [Abstract][Full Text] [Related]
30. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Agarwal PK; Sadetsky N; Konety BR; Resnick MI; Carroll PR; Cancer; 2008 Jan; 112(2):307-14. PubMed ID: 18050294 [TBL] [Abstract][Full Text] [Related]
31. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188 [TBL] [Abstract][Full Text] [Related]
32. Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience. Philippou P; Yap T; Chinegwundoh F Urol Int; 2012; 88(2):137-44. PubMed ID: 22285952 [TBL] [Abstract][Full Text] [Related]
33. The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J Urol Oncol; 2008; 26(5):500-5. PubMed ID: 18774463 [TBL] [Abstract][Full Text] [Related]
34. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446 [TBL] [Abstract][Full Text] [Related]
35. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us? Zapatero A; Mínguez R; Nieto S; Martín de Vidales C; García-Vicente F Eur Urol; 2009 Apr; 55(4):902-9. PubMed ID: 18485578 [TBL] [Abstract][Full Text] [Related]
36. Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Aizer AA; Yu JB; McKeon AM; Decker RH; Colberg JW; Peschel RE Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1344-9. PubMed ID: 19464821 [TBL] [Abstract][Full Text] [Related]
37. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome. Bachand F; Martin AG; Beaulieu L; Harel F; Vigneault E Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):679-84. PubMed ID: 18963537 [TBL] [Abstract][Full Text] [Related]
39. A report on major complications and biochemical recurrence after primary and salvage cryosurgery for prostate cancer in patients with prior resection for benign prostatic hyperplasia: a single-center experience. Ullal AV; Korets R; Katz AE; Wenske S Urology; 2013 Sep; 82(3):648-52. PubMed ID: 23831070 [TBL] [Abstract][Full Text] [Related]
40. Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. Robinson JW; Donnelly BJ; Coupland K; Siever JE; Saliken JC; Scott C; Brasher PM; Ernst DS Urol Oncol; 2006; 24(6):472-86. PubMed ID: 17138127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]